 |
 |
||||||
 |
Our customers' Feedback |
Your cart
| |||||
Generic Efavirenz - Sustiva
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.
- Sildenafil citrate and pulmonary arterial hypertension
Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure.
- Fruit and vegetables do not reduce overall cancer risk, review concludes
Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.
- Common painkillers could be linked to male reproductive disorder
The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.
Our billing is certified by:
- Efavirenz Gets Expanded Indication for HIV - Medscape
MedscapeEfavirenz Gets Expanded Indication for HIVMedscapeThe US Food and Drug Administration (FDA) has expanded the approval of efavirenz (Sustiva, Bristol-Myers Squibb) to HIV-1 infected children as young as 3 months and weighing at least 3.
- Efavirenz-based therapy produced less virologic failure in HIV-infected children - Healio
Efavirenz-based therapy produced less virologic failure in HIV-infected childrenHealioEfavirenz-based antiretroviral regimens were associated with less virological failure in HIV-infected children than nevirapine-based antiretroviral regimens, according to study results published in JAMA.
- FDA Updates Efavirenz Labeling With Expanded Pediatric Indication Information - TheBody.com
FDA Updates Efavirenz Labeling With Expanded Pediatric Indication InformationTheBody.
- Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA ... - DailyFinance
Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA .
- HIV-Infected Children: Less-Used Regimen Is More Effective for Children in Low ... - Science Daily (press release)
HIV-Infected Children: Less-Used Regimen Is More Effective for Children in Low .
|
| Copyright © reliablemedicationsrx.com is an affiliate marketing website. All rights reserved. |